Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort

References

• Port AD, Chan RV, Ostmo S, et al. Risk factors for retinopathy of prematurity: insights from outlier infants. Graefes Arch Clin Exp Ophthalmol 2014;252:1669–1677.
   PubMed Web of Science ®Google Scholar
• Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684–1694.
   PubMed Web of Science ®Google Scholar
• Axer-Siegel R, Maharshak I, Snir M, et al. Diode laser treatment of retinopathy of prematurity: anatomical and refractive outcomes. Retina 2008;28:839–846.
   PubMed Web of Science ®Google Scholar
• Axer-Siegel R, Snir M, Ron Y, et al. Intravitreal bevacizumab as supplemental treatment or monotherapy for severe retinopathy of prematurity. Retina 2011;31:1239–1247.
   PubMed Web of Science ®Google Scholar
• Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 2011;364:603–615.
   PubMed Web of Science ®Google Scholar
• Hartnett ME, Morrison MA, Smith S, et al; Genomics Subcommittee. Genetic variants associated with severe retinopathy of prematurity in extremely low birth weight infants. Invest Ophthalmol Vis Sci 2014;55:6194–6203.
   Google Scholar
• Göpel W, Kim D, Gortner L. Prothrombotic mutations as a risk factor for preterm birth. Lancet 1999;353:1411–1412.
   PubMed Web of Science ®Google Scholar
• Hiraoka M, Shastry BS. Evaluation of the prothrombin gene polymorphism in patients with advanced retinopathy of prematurity. Genet Test 2000;4:75–77.
   PubMedGoogle Scholar
• Mintz-Hittner HA, Miyashiro MJ, Knight-Nanan DM, et al. Vitreoretinal findings similar to retinopathy of prematurity in infants with compound heterozygous protein S deficiency. Ophthalmology 1999;106:1525–1530.
   PubMed Web of Science ®Google Scholar
• International Committee for the Classification of Retinopathy of Prematurity. The ınternational classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;123:991–999.
   PubMed Web of Science ®Google Scholar
• Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005;15:97–98.
   PubMed Web of Science ®Google Scholar
• Flynn JT. Retinopathy of prematurity. Pediatr Clin North Am 1987;34:1487–1516.
   PubMed Web of Science ®Google Scholar
• Pabinger I, Ay C, Dunkler D, et al. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients – results from the Vienna Cancer And Thrombosis Study (CATS). J Thromb Haemost 2015;13:17–22.
   PubMed Web of Science ®Google Scholar
• Farajzadeh M, Bargahi N, Poursadegh Zonouzi A, et al. Polymorphisms in thrombophilic genes are associated with deep venous thromboembolism in an Iranian population. Meta Gene 2014;2:505–513.
   PubMedGoogle Scholar
• Kenet G, Nowak-Göttl U. Venous thromboembolism in neonates and children. Best Pract Res Clin Haematol 2012;25:333–344.
   PubMed Web of Science ®Google Scholar
• Härtel C, König I, Köster S, et al. Genetic polymorphisms of hemostasis genes and primary outcome of very low birth weight infants. Pediatrics 2006;118:683–689.
   PubMed Web of Science ®Google Scholar
• Kenet G, Maayan-Metzger A, Rosenberg N, et al. Thrombophilia does not increase risk for neonatal complications in preterm infants. Thrombophi Thromb Haemost 2003;90:823–828.
   PubMed Web of Science ®Google Scholar
• Kleinberg S, Garrant S, Tillen T, et al. Factor V Leiden mutation (R506Q) and the risk of advanced retinopathy of prematurity. Int J Mol Med 2003;12:469–472.
   PubMed Web of Science ®Google Scholar
• Ali N, Ayyub M, Khan SA. High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident. Pak J Med Sci 2014;30:1323–1326.
   PubMed Web of Science ®Google Scholar
• Corral J1, Vicente V. Inherited thrombophilic conditions. Hematology 2012;17(Suppl. 1):S163–166.
   Google Scholar
• Desai S, Rai N, Kulkarni P, et al. Combined CRVO with CRAO in a patient with protein C deficiency. Retin Cases Brief Rep 2014;8:145–149.
   PubMedGoogle Scholar
• Muñoz-Negrete FJ, Casas-Lleras P, Pérez-López M, et al. Hypercoagulable workup in ophthalmology. When and what. Arch Soc Esp Oftalmol 2009;84:325–332.
   PubMedGoogle Scholar
• García de Frutos P, Alim RI, Härdig Y, et al. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S. Blood 1994;84:815–822.
   PubMed Web of Science ®Google Scholar
• Goodwin AJ, Rosendaal FR, Kottke-Marchant K, et al. A review of the technical, diagnostic, and epidemiologic considerations for protein S assays. Arch Pathol Lab Med 2002;126:1349–1366.
   PubMed Web of Science ®Google Scholar
• Ornstein DL, Cushman M. Cardiology patient page. Factor V Leiden. Circulation 2003;107:94–97.
   PubMed Web of Science ®Google Scholar
• Bozikova A, Gabrikova D, Pitonak J, et al. Ethnic differences in the association of thrombophilic polymorphisms with obstetric complications in Slovak and Roma (gypsy) populations. Genet Test Mol Biomarkers 2015;19:98–102.
   PubMed Web of Science ®Google Scholar
• Shang X, Luo Z, Li X, et al. Meta-analysis of Factor V Leiden G1691A polymorphism and osteonecrosis of femoral head susceptibility. Biomed Rep 2013;1:594–598.
   PubMedGoogle Scholar
• Kupeli E, Verdi H, Simsek A, et al. Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis. Clin Appl Thromb Hemost 2011;17:87–94.
   Web of Science ®Google Scholar
• Celiker G, Can U, Verdi H, et al. Prevalence of thrombophilic mutations and ACE I/D polymorphism in Turkish ischemic stroke patients. Clin Appl Thromb Hemost 2009;15:415–420.
   PubMed Web of Science ®Google Scholar
• Yasa MH, Bolaman Z, Yukselen V, et al. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients. Hepatogastroenterology 2007;54:1438–1442.
   PubMed Web of Science ®Google Scholar